The number of COVID-19 cases has continued to rise since the World Health Organization (WHO) declared the Coronavirus Disease 2019 (COVID-19) as a global pandemic in March 2020. At this time, WHO has received reports of about 460 million confirmed illnesses and over 6 million deaths. In Saudi Arabia, the number of confirmed cases has nearly surpassed 750 thousand, with COVID-19 responsible for approximately 9,000 deaths. Vaccination is the most effective approach to prevent this pandemic, and persons who have had three doses are better protected than those who have not. The goal of this study is to look into the adverse effects of COVID-19 vaccine after the third booster dosage in Saudi Arabian healthcare personnel. Between November 2021 and April 2022, a cross-sectional survey was conducted using simply a questionnaire. Pain at injection site was the commonest side effect, followed by fatigue and headache. There is a temperature and edema at the injection site, respectively. 27.71 percent of female participants experienced menstrual cycle changes such as delayed or menorrhagia. The side effects are comparable to those experienced after the first and second COVID-19 vaccination doses. More research on long-term side effects, as well as studies into the relationship between menstrual cycle changes and COVID-19 vaccination, is needed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.